Massive trial tests new Super-Pill against worms in 20,000 kids
NCT ID NCT06282315
Summary
This large study aims to see if a new combination pill (albendazole plus ivermectin) is safe and works better than the current standard pill (albendazole alone) for treating common intestinal worm infections in school-aged children. The trial will involve about 20,000 children in Ghana and Kenya, who will receive a single dose of medicine as part of a school-based treatment program. Researchers will closely monitor for side effects and check if the new pill is more effective at clearing the infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOIL-TRANSMITTED HELMINTHS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ghana Health Service (GHS)
RECRUITINGAccra, Accra, Ghana
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
-
Kenya Medical Research Institution (KEMRI)
RECRUITINGNairobi, Nairobi County, 00200, Kenya
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.